NOVOLOG PENFILLPrescription
INSULIN ASPART RECOMBINANT 300 UNITS/3ML (100 UNITS/ML) · INJECTABLE · SUBCUTANEOUS
NOVOLOG FLEXTOUCHDiscontinued
INSULIN ASPART RECOMBINANT 300 UNITS/3ML (100 UNITS/ML) · INJECTABLE · SUBCUTANEOUS
NOVOLOG FLEXPENPrescription
INSULIN ASPART RECOMBINANT 300 UNITS/3ML (100 UNITS/ML) · INJECTABLE · SUBCUTANEOUS
NOVOLOGPrescription
INSULIN ASPART RECOMBINANT 1000 UNITS/10ML (100 UNITS/ML) · INJECTABLE · SUBCUTANEOUS
NOVOLOG INNOLETDiscontinued
INSULIN ASPART RECOMBINANT 300 UNITS/3ML (100 UNITS/ML) · INJECTABLE · SUBCUTANEOUS
2023-02-28Labeling · Supplement 96 · standard — Letter ↗AP 2021-10-22Manufacturing (CMC) · Supplement 95 — Letter ↗AP 2021-03-23Labeling · Supplement 93 · standard — Letter ↗AP 2019-11-15Labeling · Supplement 90 · standard — Label ↗AP 2019-11-15Labeling · Supplement 91 · 901 required — Label ↗AP 2018-12-20Labeling · Supplement 87 · standard — Letter ↗AP 2017-03-16Labeling · Supplement 79 · standard — Label ↗AP 2016-10-07Labeling · Supplement 84 · standard — Letter ↗AP 2015-04-17Labeling · Supplement 82 · standard — Label ↗AP 2015-02-25Labeling · Supplement 81 · 901 required — Label ↗AP 2015-02-25Labeling · Supplement 59 · unknown — Letter ↗AP 2015-01-23Labeling · Supplement 80 · standard — Label ↗AP 2015-01-14Efficacy · Supplement 78 · standard — Letter ↗AP 2014-09-04Manufacturing (CMC) · Supplement 76 · standardAP
2014-09-04Manufacturing (CMC) · Supplement 77 · standardAP
2014-03-04Manufacturing (CMC) · Supplement 74 · standardAP
2014-02-25Labeling · Supplement 75 · standard — Letter ↗AP 2013-10-31Labeling · Supplement 61 · standard — Label ↗AP 2013-03-09Labeling · Supplement 67 · standard — Letter ↗AP 2012-12-13Labeling · Supplement 64 · standard — Letter ↗AP 2012-11-28Labeling · Supplement 62 · unknown — Letter ↗AP 2012-11-05Labeling · Supplement 57 · standard — Label ↗AP 2010-06-25Manufacturing (CMC) · Supplement 58 — Letter ↗AP 2010-06-25Labeling · Supplement 60 · unknown — Letter ↗AP 2009-07-17Manufacturing (CMC) · Supplement 55 — Label ↗AP 2009-07-14Manufacturing (CMC) · Supplement 45 — Label ↗AP 2009-05-07Labeling · Supplement 54 · standard — Letter ↗AP 2008-11-28Labeling · Supplement 53 · standard — Letter ↗AP 2008-09-03Labeling · Supplement 50 · standard — Letter ↗AP 2008-09-03Labeling · Supplement 49 · standard — Letter ↗AP 2008-03-14Efficacy · Supplement 47 · standard — Label ↗AP 2007-01-26Efficacy · Supplement 37 · unknown — Label ↗AP 2006-10-27Manufacturing (CMC) · Supplement 40 · standard — Review ↗AP 2005-10-21Efficacy · Supplement 32 · unknown — Label ↗AP 2005-09-13Efficacy · Supplement 33 · priority — Letter ↗AP 2004-10-08Labeling · Supplement 19 · standard — Letter ↗AP 2004-07-30Labeling · Supplement 24 · standard — Letter ↗AP 2004-04-23Manufacturing (CMC) · Supplement 23 · standard — Letter ↗AP 2004-03-19Labeling · Supplement 20 · standard — Label ↗AP 2002-12-04Efficacy · Supplement 11 · standard — Label ↗AP Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.